Bazelet Health and Sattviko to produce plant-based superfoods for the global marketplace
ORLANDO, FL -- September 28, 2021 -- InvestorsHub NewsWire --
Bazelet Health Systems Inc., (Bazelet) a wholly owned subsidiary of
Neon Bloom, Inc. (OTC:NBCO)
announced it recently signed an agreement with Sattviko, a packaged
food manufacturer. This partnership will produce a line of
superfoods infused with Bazelet Health's non-psychoactive legal
cannabis ingredients.
Sattviko is one of India's fastest growing global food
brands reaching across US, Canada, UAE, Australia, and
throughout India. Sattviko manufacturers food products that
offer solutions to many health-related issues of modern age
consumers.
Bazelet and Sattviko are furthering the global superfood
revolution with products prepared from naturally sourced raw
materials and modern technologies that preserve nutrients.
The new product line will offer healthy, super tasty foods and
snacks infused with Bazelet's federally compliant, non-psychoactive
cannabis. The products are intentionally diabetic friendly, gluten
free, act as an immune booster, are protein rich, advantageous for
the digestive tract and vegan friendly.
Cannabis can be grouped as a superfood because of its health
benefits, nutrient value, and chemical compounds. Cannabis seeds,
specifically Cannabis sativa (hemp), contain many amino acids,
proteins, and healthy fatty acids. Hemp seeds contain iron,
calcium, magnesium, phosphorus, potassium, zinc, and folate.
The new product line will be marketed in the US and several
global markets beginning late. 2021. The global superfoods market
size is expected to exceed $200B over the next five
years with impressive annual growth.
Arihant Dugar, Business Coordinator for Sattviko said: "We are
delighted to be the first food manufacturer in India to
work with Bazelet Health Systems. Our companies have a shared
vision of safe effective and affordable superfoods that advance and
promote human health and nutrition".
"Bazelet is working diligently to impact future foods and human
health utilizing infused super foods and dietary essentials"
said David Grand, Chief Research Officer for Bazelet.
About the Company: Bazelet Health
Systems, Inc. is pinpointing the genetic effects of
certain cannabis strains for optimal industrial, medicinal and
consumer application. Bazelet is the US plant patent, trademark,
and manufacturer of Panakeia™, the world's first patented cannabis
plant (US Plant Patent 32725). Panakeia™ contains 0.00%
tetrahydrocannabinol (THC) and 0.00% Cannabidiol (CBD), making it
the first and only federally legal cannabis plant.
Disclaimer: This Press Release is for
informational purposes, contains forward-looking statements based
on current forecasts and assumptions with information available to
us as of the date hereof and involve risks and uncertainties. This
does not constitute an offer to sell or a solicitation of offers to
buy any securities of any entity. Actual results may differ
materially from those stated or implied in such forward-looking
statements. Forward-looking statements include statements regarding
our expectations, beliefs, intentions or strategies regarding the
future and can be identified by forward-looking words such as
"anticipate," "believe," "could," "estimate," "expect," "intend,"
"may," "should," "would" or similar words. We assume no obligation
to update the information included in this Press Release.
CONTACT: Ryan Kelly
PHONE: (321) 558-2170
EMAIL: support@bazelethealth.com
WEBSITE: www.bazelethealth.com
SOURCE Bazelet Health
Neon Bloom (PK) (USOTC:NBCO)
過去 株価チャート
から 11 2024 まで 12 2024
Neon Bloom (PK) (USOTC:NBCO)
過去 株価チャート
から 12 2023 まで 12 2024
